B3GAT1 and melanoma: Although there were no detectable intratumoral CD56 cells at baseline or during immunotherapy, as also reported in metastatic malignant melanoma (Rubin et al, 1989), we demonstrated that mononuclear cells expressing the CD57 molecule in both peripheral blood and tumour tissue were requisite for response.